Noticias de TEM
Noticias del mercado
Últimas noticias sobre TEM — 629 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Tempus AI and Personalis (NASDAQ: PSNL) detail merger risks and upcoming SEC filings
Personalis (NASDAQ: PSNL) agrees to stock-for-stock merger with Tempus AI
Tempus AI (PSNL partner) to buy Personalis in $1.5B premium stock acquisition
Tempus AI Announces Merger Agreement to Acquire Personalis
Jefferies reiterates Tempus AI stock rating on acquisition concerns
Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis
La firma representa a la empresa de medicina de precisión basada en IA en la adquisición de la empresa de pruebas de enfermedades moleculares residuales.
Needham cuts Personalis stock rating on Tempus AI acquisition
Needham cuts Personalis stock rating on Tempus AI acquisition By Investing.com
Needham cuts Personalis stock rating on Tempus AI acquisition By Investing.com
Tempus AI stock maintains Buy rating after Personalis acquisition By Investing.com
Las acciones de Tempus AI han caído aproximadamente un 16% hasta la fecha. Cathie Wood todavía lo posee como el cuarto mayor holding de ARKK, mientras que los analistas ven un aumento de casi el 38%. Esto es lo que dice el gráfico.
Needham reiterates Tempus AI stock rating after Personalis deal By Investing.com
Tempus AI stock maintains Buy rating after Personalis acquisition By Investing.com
Needham reiterates Tempus AI stock rating after Personalis deal By Investing.com
TEM Reiterated by Needham -- Price Target Maintained at $75
Tempus AI stock maintains Buy rating after Personalis acquisition
Las acciones de Tempus AI (NASDAQ:TEM) caen cerca de $46 en el precio de fusión - TechStock²
Página 13 de 32